No time for complacency on COVID-19 in Europe

This article questions the current high level of political and societal complacency towards COVID-19 in Europe and argues that much more strategic attention and investments are needed now to more effectively manage COVID-19.

Vaccines and therapeutics for immunocompromised patients with COVID-19

Data to guide vaccination and treatment approaches in immunocompromised people are generally lacking and extrapolated from other populations. This review provides a synthesis of expert viewpoints on the issues related to immunocompromised patients in the COVID-19 pandemic era.